ヒドロコルチゾンの世界市場:規模・現状・予測2019-2025

QYResearchが発行した調査報告書(QYR20FB08441)
◆英語タイトル:Global Hydrocortisone Market Size, Status and Forecast 2019-2025
◆商品コード:QYR20FB08441
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月18日
◆ページ数:159
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,053,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、ヒドロコルチゾンの世界市場について調査・分析し、ヒドロコルチゾンの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(クリーム、インジェクション、テーブル)、用途別(副腎皮質機能障害、アドレナリン作動性症候群、高カルシウム血症、甲状腺炎、関節リウマチ、皮膚炎、喘息および慢性閉塞性肺疾患、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界のヒドロコルチゾン市場動向
・主要企業別マーケットシェア
・ヒドロコルチゾンの種類別市場規模2014-2019
(クリーム、インジェクション、テーブル)
・ヒドロコルチゾンの用途別市場規模2014-2019
(副腎皮質機能障害、アドレナリン作動性症候群、高カルシウム血症、甲状腺炎、関節リウマチ、皮膚炎、喘息および慢性閉塞性肺疾患、その他)
・ヒドロコルチゾンの北米市場:主要企業・種類別/用途別市場規模
・ヒドロコルチゾンのヨーロッパ市場:主要企業・種類別/用途別市場規模
・ヒドロコルチゾンの中国市場:主要企業・種類別/用途別市場規模
・ヒドロコルチゾンの日本国内市場:主要企業・種類別/用途別市場規模
・ヒドロコルチゾンの東南アジア市場:主要企業・種類別/用途別市場規模
・ヒドロコルチゾンのインド市場:主要企業・種類別/用途別市場規模
・ヒドロコルチゾンの中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Pfizer、Sanofi、Teva、Akorn、GSK、Bausch and Lomb、Bayer Pharmas、Macleods Pharmaceuticals、Casper Pharma、Dow Pharma、Fougera Pharms、Hikma Intl Pharms、Impax Labs、Ivax Pharms、Lannett、Merck、Novartis、Salix Pharms、Sandoz、TARO、Valeant、Wockhardt、Farmak JSC、Solvay Pharma、Alcon、Paladin Labs、Adcock Ingram、ADARE Pharmaceuticals、Aspen Holdings、Astellas Pharma)
・ヒドロコルチゾンの市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

In 2018, the global Hydrocortisone market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hydrocortisone status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hydrocortisone development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Pfizer
Sanofi
Teva
Akorn
GSK
Bausch and Lomb
Bayer Pharmas
Macleods Pharmaceuticals
Casper Pharma
Dow Pharma
Fougera Pharms
Hikma Intl Pharms
Impax Labs
Ivax Pharms
Lannett
Merck
Novartis
Salix Pharms
Sandoz
TARO
Valeant
Wockhardt
Farmak JSC
Solvay Pharma
Alcon
Paladin Labs
Adcock Ingram
ADARE Pharmaceuticals
Aspen Holdings
Astellas Pharma

Market segment by Type, the product can be split into
Cream
Injection
Table

Market segment by Application, split into
Adrenocortical Dysfunction
Adrenergic Syndrome
High Blood Calcium
Thyroiditis
Rheumatoid Arthritis
Dermatitis
Asthma and Chronic Obstructive Pulmonary Disease
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hydrocortisone status, future forecast, growth opportunity, key market and key players.
To present the Hydrocortisone development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hydrocortisone are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hydrocortisone Market Size Growth Rate by Type (2014-2025)
1.4.2 Cream
1.4.3 Injection
1.4.4 Table
1.5 Market by Application
1.5.1 Global Hydrocortisone Market Share by Application (2019-2025)
1.5.2 Adrenocortical Dysfunction
1.5.3 Adrenergic Syndrome
1.5.4 High Blood Calcium
1.5.5 Thyroiditis
1.5.6 Rheumatoid Arthritis
1.5.7 Dermatitis
1.5.8 Asthma and Chronic Obstructive Pulmonary Disease
1.5.9 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hydrocortisone Market Size
2.2 Hydrocortisone Growth Trends by Regions
2.2.1 Hydrocortisone Market Size by Regions (2019-2025)
2.2.2 Hydrocortisone Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Hydrocortisone Market Size by by Players
3.1.1 Global Hydrocortisone Revenue by by Players (2014-2019)
3.1.2 Global Hydrocortisone Revenue Market Share by by Players (2014-2019)
3.1.3 Global Hydrocortisone Market Concentration Ratio (CR5 and HHI)
3.2 Hydrocortisone Key Players Head office and Area Served
3.3 Key Players Hydrocortisone Product/Solution/Service
3.4 Date of Enter into Hydrocortisone Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hydrocortisone Market Size by Type (2014-2019)
4.2 Global Hydrocortisone Market Size by Application (2014-2019)

5 North America
5.1 North America Hydrocortisone Market Size (2014-2019)
5.2 Hydrocortisone Key Players in North America
5.3 North America Hydrocortisone Market Size by Type
5.4 North America Hydrocortisone Market Size by Application

6 Europe
6.1 Europe Hydrocortisone Market Size (2014-2019)
6.2 Hydrocortisone Key Players in Europe
6.3 Europe Hydrocortisone Market Size by Type
6.4 Europe Hydrocortisone Market Size by Application

7 China
7.1 China Hydrocortisone Market Size (2014-2019)
7.2 Hydrocortisone Key Players in China
7.3 China Hydrocortisone Market Size by Type
7.4 China Hydrocortisone Market Size by Application

8 Japan
8.1 Japan Hydrocortisone Market Size (2014-2019)
8.2 Hydrocortisone Key Players in Japan
8.3 Japan Hydrocortisone Market Size by Type
8.4 Japan Hydrocortisone Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hydrocortisone Market Size (2014-2019)
9.2 Hydrocortisone Key Players in Southeast Asia
9.3 Southeast Asia Hydrocortisone Market Size by Type
9.4 Southeast Asia Hydrocortisone Market Size by Application

10 India
10.1 India Hydrocortisone Market Size (2014-2019)
10.2 Hydrocortisone Key Players in India
10.3 India Hydrocortisone Market Size by Type
10.4 India Hydrocortisone Market Size by Application

11 Central & South America
11.1 Central & South America Hydrocortisone Market Size (2014-2019)
11.2 Hydrocortisone Key Players in Central & South America
11.3 Central & South America Hydrocortisone Market Size by Type
11.4 Central & South America Hydrocortisone Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hydrocortisone Introduction
12.1.4 Pfizer Revenue in Hydrocortisone Business (2014-2019))
12.1.5 Pfizer Recent Development
12.2 Sanofi
12.2.1 Sanofi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hydrocortisone Introduction
12.2.4 Sanofi Revenue in Hydrocortisone Business (2014-2019)
12.2.5 Sanofi Recent Development
12.3 Teva
12.3.1 Teva Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hydrocortisone Introduction
12.3.4 Teva Revenue in Hydrocortisone Business (2014-2019)
12.3.5 Teva Recent Development
12.4 Akorn
12.4.1 Akorn Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hydrocortisone Introduction
12.4.4 Akorn Revenue in Hydrocortisone Business (2014-2019)
12.4.5 Akorn Recent Development
12.5 GSK
12.5.1 GSK Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hydrocortisone Introduction
12.5.4 GSK Revenue in Hydrocortisone Business (2014-2019)
12.5.5 GSK Recent Development
12.6 Bausch and Lomb
12.6.1 Bausch and Lomb Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hydrocortisone Introduction
12.6.4 Bausch and Lomb Revenue in Hydrocortisone Business (2014-2019)
12.6.5 Bausch and Lomb Recent Development
12.7 Bayer Pharmas
12.7.1 Bayer Pharmas Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hydrocortisone Introduction
12.7.4 Bayer Pharmas Revenue in Hydrocortisone Business (2014-2019)
12.7.5 Bayer Pharmas Recent Development
12.8 Macleods Pharmaceuticals
12.8.1 Macleods Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hydrocortisone Introduction
12.8.4 Macleods Pharmaceuticals Revenue in Hydrocortisone Business (2014-2019)
12.8.5 Macleods Pharmaceuticals Recent Development
12.9 Casper Pharma
12.9.1 Casper Pharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hydrocortisone Introduction
12.9.4 Casper Pharma Revenue in Hydrocortisone Business (2014-2019)
12.9.5 Casper Pharma Recent Development
12.10 Dow Pharma
12.10.1 Dow Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Hydrocortisone Introduction
12.10.4 Dow Pharma Revenue in Hydrocortisone Business (2014-2019)
12.10.5 Dow Pharma Recent Development
12.11 Fougera Pharms
12.12 Hikma Intl Pharms
12.13 Impax Labs
12.14 Ivax Pharms
12.15 Lannett
12.16 Merck
12.17 Novartis
12.18 Salix Pharms
12.19 Sandoz
12.20 TARO
12.21 Valeant
12.22 Wockhardt
12.23 Farmak JSC
12.24 Solvay Pharma
12.25 Alcon
12.26 Paladin Labs
12.27 Adcock Ingram
12.28 ADARE Pharmaceuticals
12.28 Aspen Holdings
12.40 Astellas Pharma

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Pfizer、Sanofi、Teva、Akorn、GSK、Bausch and Lomb、Bayer Pharmas、Macleods Pharmaceuticals、Casper Pharma、Dow Pharma、Fougera Pharms、Hikma Intl Pharms、Impax Labs、Ivax Pharms、Lannett、Merck、Novartis、Salix Pharms、Sandoz、TARO、Valeant、Wockhardt、Farmak JSC、Solvay Pharma、Alcon、Paladin Labs、Adcock Ingram、ADARE Pharmaceuticals、Aspen Holdings、Astellas Pharma

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒドロコルチゾンの世界市場:規模・現状・予測2019-2025(Global Hydrocortisone Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。